| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LGND | LIGAND PHARMACEUTICALS INC | Reardon Andrew | CHIEF LEGAL OFFICER & | Feb 15, 2024 | Option Exercise | $74.65 | 593 | 44,267 | 14,997 | Feb 16, 2024, 08:10 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Reardon Andrew | CHIEF LEGAL OFFICER & | Dec 29, 2023 | Option Exercise | $60.71 | 179 | 10,867 | 15,590 | Jan 04, 2024, 04:07 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Reardon Andrew | CHIEF LEGAL OFFICER & | Aug 10, 2023 | Option Exercise | $68.73 | 897 | 61,651 | 15,411 | Aug 14, 2023, 04:20 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Reardon Andrew | See Remarks | Mar 24, 2023 | Sale | $69.92 | 300 | 20,977 | 16,308 | Mar 28, 2023, 05:00 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Reardon Andrew | See Remarks | Nov 30, 2022 | Option Exercise | $72.90 | 1,073 | 78,222 | 10,940 | Dec 01, 2022, 09:39 PM |
Menu